Tao Jiang

3.3k total citations
100 papers, 2.3k citations indexed

About

Tao Jiang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tao Jiang has authored 100 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 37 papers in Cancer Research and 27 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tao Jiang's work include Cancer-related molecular mechanisms research (22 papers), RNA modifications and cancer (21 papers) and Ferroptosis and cancer prognosis (15 papers). Tao Jiang is often cited by papers focused on Cancer-related molecular mechanisms research (22 papers), RNA modifications and cancer (21 papers) and Ferroptosis and cancer prognosis (15 papers). Tao Jiang collaborates with scholars based in China, United States and Germany. Tao Jiang's co-authors include Jinbo Zhao, Lize Xiong, Yanlu Xiong, Yunfeng Ni, Qian Zhai, Feng Tian, Xiaolong Yan, Fuhai Bai, Qiang Wang and Qiang Wang and has published in prestigious journals such as Journal of Clinical Oncology, Molecular and Cellular Biology and Scientific Reports.

In The Last Decade

Tao Jiang

98 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tao Jiang China 30 1.1k 641 380 294 279 100 2.3k
Xueqian Wang China 22 895 0.8× 274 0.4× 351 0.9× 222 0.8× 272 1.0× 79 2.0k
Bin Hu China 27 1.2k 1.1× 441 0.7× 172 0.5× 187 0.6× 159 0.6× 70 2.6k
Zhihong Jian China 27 1.0k 0.9× 328 0.5× 344 0.9× 438 1.5× 853 3.1× 73 2.7k
Hui Zhao China 28 886 0.8× 287 0.4× 173 0.5× 231 0.8× 571 2.0× 157 2.4k
Yan Zhou China 27 1.2k 1.1× 433 0.7× 184 0.5× 284 1.0× 223 0.8× 95 2.3k
Ping Xie China 28 1.4k 1.2× 346 0.5× 213 0.6× 507 1.7× 209 0.7× 128 3.4k
Hai Jin China 26 947 0.8× 340 0.5× 213 0.6× 134 0.5× 145 0.5× 74 1.8k
Tao Tao China 28 1.2k 1.0× 736 1.1× 164 0.4× 281 1.0× 511 1.8× 69 2.4k
Qin Hu China 31 1.3k 1.2× 316 0.5× 161 0.4× 378 1.3× 624 2.2× 107 3.1k

Countries citing papers authored by Tao Jiang

Since Specialization
Citations

This map shows the geographic impact of Tao Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Jiang more than expected).

Fields of papers citing papers by Tao Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tao Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Jiang. The network helps show where Tao Jiang may publish in the future.

Co-authorship network of co-authors of Tao Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Tao Jiang. A scholar is included among the top collaborators of Tao Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tao Jiang. Tao Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Tao, Michael Reng, Yuwei Ma, et al.. (2025). Integration of temperature-sensitive hydrogels loaded with realgar and magnetic particles for lung cancer diagnosis and treatment. Cancer Nanotechnology. 16(1). 3 indexed citations
2.
Xiong, Yanlu, Jie Lei, Yongfu Ma, et al.. (2025). CENPF (+) cancer cells promote malignant progression of early-stage TP53 mutant lung adenocarcinoma. Oncogenesis. 14(1). 5–5. 1 indexed citations
4.
Zhang, Wenwen, et al.. (2024). Paeoniflorin inhibited GSDMD to alleviate ANIT-induced cholestasis via pyroptosis signaling pathway. Phytomedicine. 134. 156021–156021. 9 indexed citations
5.
Zhang, Yue, et al.. (2024). LRP1-mediated p-tau propagation contributes to cognitive impairment after chronic neuropathic pain in rats. Neuroscience Research. 212. 84–96. 1 indexed citations
6.
Hu, Qichao, Tao Jiang, Pan Gao, et al.. (2024). Paeoniflorin alleviates DSS-induced ulcerative colitis by suppressing inflammation, oxidative stress, and apoptosis via regulating serum metabolites and inhibiting CDC42/JNK signaling pathway. International Immunopharmacology. 142(Pt A). 113039–113039. 6 indexed citations
7.
Liu, Tianhua, Wei Hong, Lijuan Zhang, et al.. (2024). Metformin attenuates lung ischemia-reperfusion injury and necroptosis through AMPK pathway in type 2 diabetic recipient rats. BMC Pulmonary Medicine. 24(1). 237–237. 2 indexed citations
8.
Lan, Ke, Xiaolong Yan, Jie Lei, et al.. (2024). Clinical outcomes and short-term survival of neoadjuvant immunochemotherapy for resectable esophageal cancer: a multicenter retrospective cohort study. International Journal of Surgery. 111(1). 1547–1551.
9.
Jiang, Tao, Xianwei Wang, Jiaming Huang, & Dong Chen. (2023). CDC42—A promising immune-related target in glioma. Frontiers in Neuroscience. 17. 1192766–1192766. 5 indexed citations
10.
Jiang, Tao, Yanmin Xia, Wenzhe Wang, et al.. (2023). Apoptotic bodies inhibit inflammation by PDL1–PD1‐mediated macrophage metabolic reprogramming. Cell Proliferation. 57(1). e13531–e13531. 13 indexed citations
11.
Chen, Xiaojing, Xiaofeng Wang, Deng Zhang, et al.. (2023). Nerve conduction velocity is independently associated with bone mineral density in type 2 diabetes mellitus. Frontiers in Endocrinology. 14. 1109322–1109322. 4 indexed citations
12.
Tian, Feng, Jie Lei, Yunfeng Ni, et al.. (2022). Regulation of CD18 stability by SIGIRR ‐modulated ubiquitination: new insights into the relationship between innate immune response and acute lung injury. FEBS Journal. 290(10). 2721–2743. 3 indexed citations
13.
Tang, Xiyang, Yanlu Xiong, Ying Sun, et al.. (2022). The downregulation of fibrinogen-like protein 1 inhibits the proliferation of lung adenocarcinoma via regulating MYC-target genes. Translational Lung Cancer Research. 11(3). 404–419. 10 indexed citations
15.
Jiang, Tao, Na Duan, Meiyan Wu, et al.. (2020). Activation of CB1R-Dependent PGC-1α Is Involved in the Improved Mitochondrial Biogenesis Induced by Electroacupuncture Pretreatment. Rejuvenation Research. 24(2). 104–119. 9 indexed citations
16.
Yang, Ting, Pei-Cong Shi, Man-Ru Liu, et al.. (2020). Long noncoding RNA MAPKAPK5-AS1 promotes colorectal cancer progression by cis-regulating the nearby gene MK5 and acting as a let-7f-1-3p sponge. Journal of Experimental & Clinical Cancer Research. 39(1). 139–139. 46 indexed citations
17.
Shi, Zhang, Xuan Zheng, Ruifeng Shi, et al.. (2018). Score for lung adenocarcinoma in China with EGFR mutation of exon 19. Medicine. 97(38). e12537–e12537. 3 indexed citations
18.
Bai, Fuhai, Fan Guo, Tao Jiang, et al.. (2016). Arachidonyl-2-Chloroethylamide Alleviates Cerebral Ischemia Injury Through Glycogen Synthase Kinase-3β-Mediated Mitochondrial Biogenesis and Functional Improvement. Molecular Neurobiology. 54(2). 1240–1253. 30 indexed citations
20.
Han, Yong, Kun Liu, Xiaofei Li, et al.. (2009). Repair of massive stent-induced tracheoesophageal fistula. Journal of Thoracic and Cardiovascular Surgery. 137(4). 813–817. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026